## **Core Concept**
Sjögren's syndrome is a chronic autoimmune disorder characterized by inflammation of the exocrine glands, particularly the salivary and lacrimal glands. This inflammation leads to reduced glandular secretions, causing symptoms like dry mouth (xerostomia) and dry eyes (xerophthalmia). The condition affects the **parasympathetic and sympathetic nerves** that regulate salivary secretion, but primarily, it's an autoimmune-mediated destruction of the **salivary gland tissues**.

## **Why the Correct Answer is Right**
In Sjögren's syndrome, the autoimmune destruction of the salivary glands results in a significant reduction in salivary flow. The normal salivary flow rate can vary but is typically around 1-2 mL/min per gland. In patients with Sjögren's syndrome, the **stimulated salivary flow rate** from each parotid gland can decrease to less than 0.5 mL/min, often cited as ≤0.5 mL/min or even much lower. This drastic reduction leads to xerostomia and its associated complications.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option suggests a very high flow rate that is not consistent with the pathophysiology of Sjögren's syndrome.
- **Option B:** This option might seem plausible but still represents a relatively normal or slightly reduced flow rate, not reflective of the significant reduction seen in Sjögren's syndrome.
- **Option D:** This option suggests a minimal reduction in salivary flow, which does not align with the significant impairment characteristic of Sjögren's syndrome.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with Sjögren's syndrome are at increased risk of dental caries, oral infections, and difficulties with swallowing due to decreased saliva production. **Stimulated salivary flow rate** is a critical diagnostic criterion and can guide management strategies.

## **Correct Answer:** . ≤0.5 mL/min